Orlistat for Obesity
Orlistat, a lipase inhibitor that decreases absorption of fat from the gastrointestinal tract, is now available for treatment of obesity....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Orlistat for Obesity
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1055
Article Code: 1055a
Date: June 18, 1999
Volume: 41
Pages: 55-56
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1055
Article Code: 1055a
Date: June 18, 1999
Volume: 41
Pages: 55-56
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)